文献速递神经康复言语与吞咽障碍

经皮电刺激治疗慢性卒中后口咽吞咽障碍:随机对照试验1年结果

Effect of Transcutaneous Electrical Stimulation in Chronic Poststroke Patients with Oropharyngeal Dysphagia: 1-Year Results of a Randomized Controlled Trial.
PubMed 文献 · Neurorehabil Neural Repair · 2021-06-17

结果显示SES和NMES组在安全吞咽率、PAS评分、喉前庭闭合时间及增稠剂需求方面均显著改善,且无严重不良事件。

要点

  • SES和NMES均显著改善慢性卒中后吞咽障碍患者的安全吞咽率(P<.001)。
  • 两种电刺激均显著降低PAS评分和喉前庭闭合延迟时间(P<.001,P<.01)。
  • 电刺激显著减少增稠剂需求(P<.001),且无严重不良事件。

核心结论

  • 经皮电刺激是老年CPSOD患者安全有效的治疗方法,1年随访显著改善吞咽安全性并减少液体增稠需求。

研究设计与样本

  • 患者接受最多两个周期(间隔6个月)的15次×1小时TES治疗,为期两周,并在1年内进行4-5次临床和视频透视评估。

主要发现

  • 基线PAS为4.61±1.75,喉前庭闭合延迟时间396.4±108.7 ms,吞咽效率受损体征占94.25%。
  • SES和NMES组在1年随访时安全吞咽患者比例、平均PAS、喉前庭闭合时间及增稠剂需求均较基线显著改善(P<.001,P<.001,P<.01,P<.001)。
  • CT组吞咽安全性体征改善较弱,喉前庭闭合时间无显著变化。
  • 1年死亡率6.1%、呼吸道感染9.6%、再入院率27.6%,组间无差异;营养和功能状态、生活质量组间亦无差异。
  • 未观察到与TES相关的显著不良事件。

临床怎么用

  • 对于慢性卒中后口咽吞咽障碍患者,可考虑使用SES或NMES作为补偿治疗的辅助手段,以改善吞咽安全性和减少增稠剂使用。
  • 治疗耐受性良好,未报告严重不良事件,适合老年患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background. Chronic poststroke oropharyngeal dysphagia (CPSOD) is associated with impaired oropharyngeal sensory/motor function. We aimed to assess effect of sensory (SES) and motor (NMES) transcutaneous electrical stimulation (TES) on safety of swallow and clinical outcomes in patients with CPSOD in a one-year follow-up randomized controlled trial. Methods. Ninety patients (74.1 ± 11.5 y, modified Rankin score 2.6 ± 1.7) with CPSOD and impaired safety of swallow were randomized to (a) compensatory treatment (CT), (b) CT + SES, and (c) CT + NMES. Patients were treated with up to two cycles (6 months apart) of 15 × 1 hour TES sessions over two weeks and followed up with 4-5 clinical and videofluoroscopic assessments during one year. Key results. Baseline penetration-aspiration scale (PAS) was 4.61 ± 1.75, delayed time to laryngeal vestibule closure (LVC) 396.4 ± 108.7 ms, and impaired efficacy signs 94.25%. Swallowing parameters significantly improved between baseline and 1-year follow-up in SES and NMES groups for prevalence of patients with a safe swallow (P < .001), mean PAS (P < .001), time to LVC (P < .01), and need for thickening agents (P < .001). Patients in the CT presented a less intense improvement of signs of impaired safety of swallow without significant changes in time to LVC. No differences between groups were observed for 1-year mortality (6.1%), respiratory infections (9.6%), nutritional and functional status, QoL, and hospital readmission rates (27.6%). No significant adverse events related to TES were observed. Conclusions and inferences. Transcutaneous electrical stimulation is a safe and effective therapy for older patients with CPSOD. After 1-year follow-up, TES greatly improved the safety of swallow and reduced the need for fluid thickening in these patients.

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Arreola V, Ortega O, Álvarez-Berdugo D, et al. Effect of Transcutaneous Electrical Stimulation in Chronic Poststroke Patients with Oropharyngeal Dysphagia: 1-Year Results of a Randomized Controlled Trial. Neurorehabil Neural Repair. 2021. PMID: 34137329. doi:10.1177/15459683211023187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。